Breakthrough: AI and better medicines

Many diseases occur because of defects in particular proteins—the workhorses of every cell. But developing a drug that targets a defective protein requires knowing that protein’s shape. Protein shapes have always been difficult to predict. Then in July 2021, a company called DeepMind reported that its software predicted the structures for 98% of human proteins. By the end of 2021, DeepMind says it will publish the shape of 50% of the 280 million nonhuman proteins, up from 0.01%. These breakthroughs are expected to lead to new medicines.